Coenzyme Q10

Generic Name
Coenzyme Q10
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C59H90O4
CAS Number
303-98-0
Unique Ingredient Identifier
EJ27X76M46
Background

Ubidecarenone, also called coenzyme Q10, is a 1,4-benzoquinone. From its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail. It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation. The ubidecarenone is the coenzyme destined for ...

Indication

The diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia...

Associated Conditions
Migraine
Associated Therapies
-
Clinical Trials
Related News
expresspharma.in
·

Miror launches Miror Bliss to address perimenopause and menopause health needs

Miror Bliss, a FemTech supplement, aims to support Indian women experiencing perimenopause and menopause, addressing common symptoms and promoting holistic health with 18 scientifically selected ingredients. The product targets hormonal imbalances, hot flashes, mood swings, and sleep disturbances, reflecting the growing demand for targeted wellness solutions in India.
genengnews.com
·

Ten Companies to Watch in AI Drug Discovery

Niven R. Narain emphasizes that AI investments in drug development require robust data and validation. GEN's A-List highlights 10 AI-based drug discovery leaders, including BPGbio, which focuses on cancer energy generation. Other notable companies include Nvidia and Palantir Technologies, though not on the A-List. The list includes specifics on companies like Anima Biotech, Atomwise, and Nimbus Therapeutics, detailing their AI platforms and drug development progress.
silicon.co.uk
·

BPGbio Recognized as 2024 'BioTech AI Company of the Year' by BioTech Breakthrough Awards

BPGbio, a biology-first, AI-powered biopharma, was named 'BioTech AI Company of the Year' at the 2023 BioTech Breakthrough Awards for its NAi Interrogative Biology® Platform. The platform, leveraging causal AI and the world's fastest supercomputer, accelerates drug discovery and development, focusing on mitochondrial biology and protein homeostasis. BPGbio's 2024 milestones include Phase 2 oncology trials, Rare Pediatric Disease Phase 3 trials, and breakthroughs in protein degradation.
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy